279. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID)

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)35292-3
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy